Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery

Journal of Controlled Release

Volumn 66, Issue 2-3, 2000, Pages 229-241

  Tinsley Bown, A M ^a   Fretwell, R ^a   Dowsett, A B ^a   Davis, S L ^a   Farrar, G H ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Controlled release; DNA delivery; Microencapsulation; Poly(D,L lactic co glycolic acid); Vaccines

Indexed keywords

DNA VACCINE; OIL; PLASMID DNA; POLYGLACTIN; POLYMER; POLYVINYL ALCOHOL; SOLVENT; WATER;

AGAR GEL ELECTROPHORESIS; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG FORMULATION; EMULSION; MICROENCAPSULATION; MICROPARTICLE; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

DNA; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROPHORESIS, AGAR GEL; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PLASMIDS; POLYGLYCOLIC ACID; POLYMERS; VISCOSITY;

EID: 0034657718     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00275-8     Document Type: Article

References (30)

1. Chasin M., Langer R. Biodegradable Polymers as Drug Delivery Systems. 1990;Marcel Dekker, New York.
2. Kreuter J. Nanoparticles and microparticles for drug and vaccine delivery. J. Anat. 189:1996;503-505.
3. Morris W., Steinhoff M.C., Russell P.K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine. 12:(1):1994;5-11.
4. Takenaga M., Serizawa Y., Azechi Y., Ochiai A., Kosaka Y., Igarashi R., Mizushima Y. Microparticle resins as a potential nasal drug delivery system for insulin. J. Control. Release. 52:1998;81-87.
5. Hilbert A.K., Fritzsche U., Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine. 17:1999;1065-1073.
6. Gallardo A., Eguiburu J.L., Berridi M.J.F., Roman J.S. Preparation and in vitro release studies of ibuprofen-loaded films and microspheres made from graft copolymers of poly(L-lactic acid) on acrylic backbones. J. Control. Release. 55:1998;171-179.
7. Géze A., Venier-Julienne M.-C., Saulnier P., Varlet P., Daumas-Duport C., Devauchelle P., Benoit J.-P. Modulated release of IdUrd from poly(D,L-lactide-co-glycolide) microspheres by addition of poly(D,L-lactide) oligomers. J. Control. Release. 58:1999;311-322.
8. Visscher G.E., Robinson R.L., Mauling H.V., Fong J.W., Pearson J.E., Argentieri G.J. Biodegradation and tissue reaction to 50:50 poly(D,L-lactide-co-glycilide) microcapsules. J. Biomed. Mater. Res. 19:1985;349-365.
9. Kim S.Y., Doh H.J., Ahn J.S., Ha Y.J., Jang M.H., Chung S.I., Park H.J. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles. Vaccine. 17:1999;607-616.
10. Singh M., Li X.-M., Wang H., McGee J.P., Zamb T., Koff W., Wang C.Y., O'Hagan D.T. Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models. Vaccine. 16:(4):1998;346-352.
11. Chattaraj S.C., Rathinavelu A., Das S.K. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice. J. Control. Release. 58:1999;223-232.
12. Jones D.H., McBride B.W., Thornton C., O'Hagan D.T., Robinson A., Farrar G.H. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. Infect. Immun. 64:(2):1996;489-494.
13. Jones D.H., McBride B.W., Jeffery H., O'Hagan D.T., Robinson A., Farrar G.H. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine. 13:(7):1995;675-681.
14. Wang D., Robinson D.R., Kwon G.S., Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Control. Release. 57:1999;9-18.
15. M.L. Hedley, J.M. Curley, R. Langer, L.B. Lunsford, Microparticles for delivery of nucleic acid, W.O. 98/31398, January 22, 1998.
16. Jones D.H., Partidos C.D., Steward M.W., Farrar G.H. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines. Behring. Inst. Mitt. 98:1997;220-228.
17. Jones D.H., Corris S., McDonald S., Clegg J.C.S., Farrar G.H. Poly(D,L-lactide-co-glycolide) encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:(8):1997;814-817.
18. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C.S., Greenberg H.B., Herrmann J.E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:(7):1998;5757-5761.
19. Herrmann J.E., Chen S.C., Jones D.H., Tinsley-Bown A., Fynan E.F., Greenberg H.B., Farrar G.H. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 vaccines encapsulated in microparticles. Virology. 259:1999;148-153.
20. D.H. Jones, G.H. Farrar, Microencapsulated DNA for vaccination and gene therapy, PCT/GB95/23019, November 11, 1995.
21. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
22. Kimoto H., Taketo A. Studies on electrotransfer of DNA into Escherichia coli: effect of molecular form of DNA. Biochim. Biophys. Acta. 1307:1996;325-330.
23. Xie T.D., Sun L., Zhao H.G., Fuchs J.A., Tsong T.Y. Study of mechanisms of electric field-induced DNA transfection IV: Effects of DNA topology on cell uptake and transfection efficiency. Biophys. J. 63:1992;1026-1031.
24. Jones D.H., Clegg J.C.S., Farrar G.H. Oral delivery of microencapsulated DNA vaccines. Dev. Biol. Stand. 92:1998;149-155.
25. Sah H.K., Toddywala R., Chien Y.W. Biodegradable microcapsules prepared by a w/o/w technique: effects of shear forces to make a primary w/o emulsion on their morphology and protein release. J. Microencapsulation. 12:(1):1995;59-69.
26. Cleland J.L. Single-administration vaccines: controlled-release technology to mimic repeated immunizations. Tibtechnology. 17:1999;25-29.
27. Jeyanthi R., Thanoo B.C., Metha R.C., DeLuca P.P. Effect of solvent removal techniques on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J. Control. Release. 38:1996;235-244.
28. Hausberger A.G., DeLuca P.P. Characterisation of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres. J. Pharm. Biomed. Anal. 13:(6):1995;747-760.
29. Lewis D.H. Chasin M., Langer R. Biodegradable Polymers as Drug Delivery Systems. 1990;1-41 Marcel Dekker, New York.
30. O'Hagan D.T., Singh M., Gupta R.K. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled release vaccines. Adv. Drug Deliv. Rev. 32:1998;225-246.